Literature DB >> 16755346

Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.

Marie-Laure Leichtnam1, Hervé Rolland, Patrick Wüthrich, Richard H Guy.   

Abstract

In the human male, testosterone is the major circulating androgen. The clinical effects of androgen are numerous, and testosterone deficiency is associated with a number of clinical abnormalities. At present, a variety of preparations containing testosterone is available for the treatment of androgen deficiency. Ideally, those treatments have to produce and maintain physiologic serum concentrations of the hormone. This article reviews the current existing testosterone dosage forms on the market with their advantages and drawbacks and examines new and emerging technology developments concerning this therapy. In particular, the latest innovations in transdermal delivery are explored.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755346     DOI: 10.1007/s11095-006-0072-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  91 in total

1.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  Low-frequency sonophoresis: a noninvasive method of drug delivery and diagnostics.

Authors:  S Mitragotri; J Kost
Journal:  Biotechnol Prog       Date:  2000 May-Jun

3.  Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.

Authors:  H M Behre; K Abshagen; M Oettel; D Hübler; E Nieschlag
Journal:  Eur J Endocrinol       Date:  1999-05       Impact factor: 6.664

4.  Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major.

Authors:  V De Sanctis; C Vullo; L Urso; F Rigolin; A Cavallini; K Caramelli; C Daugherty; N Mazer
Journal:  J Pediatr Endocrinol Metab       Date:  1998       Impact factor: 1.634

Review 5.  Testosterone deficiency and replacement.

Authors:  S Howell; S Shalet
Journal:  Horm Res       Date:  2001

Review 6.  Testosterone deficiency in women: etiologies, diagnosis, and emerging treatments.

Authors:  Norman A Mazer
Journal:  Int J Fertil Womens Med       Date:  2002 Mar-Apr

7.  Development of a novel soft hydrogel for the transdermal delivery of testosterone.

Authors:  Na-Mi An; Dae-Duk Kim; Young-Hee Shin; Chi-Ho Lee
Journal:  Drug Dev Ind Pharm       Date:  2003-01       Impact factor: 3.225

8.  Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.

Authors:  H M Behre; S Baus; S Kliesch; C Keck; M Simoni; E Nieschlag
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

9.  AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

Authors:  C Steidle; S Schwartz; K Jacoby; T Sebree; T Smith; R Bachand
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  Randomized clinical trial of testosterone replacement therapy in hypogonadal men.

Authors:  A J Conway; L M Boylan; C Howe; G Ross; D J Handelsman
Journal:  Int J Androl       Date:  1988-08
View more
  2 in total

1.  Klinefelter syndrome presenting as behavioral problems in a young adult.

Authors:  Alexandra M Molnar; Genji S Terasaki; John K Amory
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

Review 2.  Testosterone Use in Adolescent Males: Current Practice and Unmet Needs.

Authors:  Maria Vogiatzi; James P Tursi; Jonathan S Jaffe; Sue Hobson; Alan D Rogol
Journal:  J Endocr Soc       Date:  2020-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.